ArticleFrontiers in neuroinformatics2026
A deep learning based NeuroFusionNet approach for automated brain tumor diagnosis from MRI.
Article in Frontiers in neuroinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Brain tumor diagnosis from magnetic resonance imaging (MRI) remains a challenging task due to the high variability in tumor appearance and the limitations of manual interpretation. Methods: To address these challenges, this paper proposes NeuroFusionNet, a deep learning framework for automated brain tumor classification from MRI. The framework integrates GAN-based synthetic image generation with transfer learning using a fine-tuned VGG16 backbone. Real and GAN-generated MRI images are passed through VGG16 to extract discriminative feature representations, which are then used for final classification. To adapt the model to domain-specific MRI characteristics while preserving pretrained knowledge, the last ten layers of VGG16 are fine-tuned and the remaining layers are kept frozen. Results: The effectiveness of NeuroFusionNet is validated on two publicly available brain MRI datasets. Experimental results demonstrate that the proposed learning framework achieves classification accuracies of 99.05 and 98.75% on the Brain Tumor MRI Dataset and the MRI with Bounding Boxes Dataset, respectively, consistently outperforming several state-of-the-art neural architectures, including VGG16, VGG19, MobileNetV2, DenseNet121, and NASNetLarge. Conclusion: The results suggest that NeuroFusionNet is effective for the evaluated public MRI datasets; additional external validation is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.